# acthar_analysis

Analysis for data-driven investigation into how an extremely expensive drug designed for infant seizures was dubiously marketed to the elderly. The analysis found 80 percent of the doctors prescribing the drug to Medicare patients had received payments in the form of perks from the manufacturer.  

All told Medicare spent roughly $2 billion on the drug, which hasn't found to be any more effective than comparable treatments costing only a few dollars.

https://www.cnn.com/2018/06/29/health/acthar-mallinckrodt-medicare-claims-doctor-payments/index.html

